Middle East & Africa Drug Discovery Informatics Market Size & Outlook
Related Markets
MEA drug discovery informatics market highlights
- The MEA drug discovery informatics market generated a revenue of USD 103.4 million in 2024.
- The market is expected to grow at a CAGR of 10.2% from 2025 to 2030.
- In terms of segment, sequence analysis platforms was the largest revenue generating service in 2024.
- Sequence Analysis Platforms is the most lucrative service segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 103.4 million |
| Market revenue in 2030 | USD 184.6 million |
| Growth rate | 10.2% (CAGR from 2025 to 2030) |
| Largest segment | Sequence analysis platforms |
| Fastest growing segment | Sequence Analysis Platforms |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management |
| Key market players worldwide | Certara Inc Ordinary Shares, Boehringer Ingelheim, Infosys Ltd ADR, Charles River Laboratories International Inc, Eli Lilly and Co, Novo Nordisk A/S ADR, Oracle Corp, Accenture PLC Class A, Agilent Technologies Inc, Illumina Inc, Eurofins Scientific SE, Jubilant Biosys, Selvita, ChemAxon, Albany Molecular Research |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.8% of the global drug discovery informatics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,748.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Discovery Informatics Market Scope
Drug Discovery Informatics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Albany Molecular Research | View profile | 1001-5000 | Albany, New York, United States, North America | http://amriglobal.com |
| ChemAxon | View profile | 101-250 | Utica, New York, United States, North America | https://chemaxon.com/company |
| Selvita | View profile | 501-1000 | Sedziszow Malopolski, Podkarpackie, Poland, Europe | http://www.selvita.com/ |
| Jubilant Biosys | View profile | 501-1000 | Bengaluru, Karnataka, India, Asia | https://www.jubilantbiosys.com/ |
| Certara Inc Ordinary Shares | View profile | 1391 | 100 Overlook Center, Suite 101, Princeton, NJ, United States, 08540 | https://www.certara.com |
| Infosys Ltd ADR | View profile | 322663 | 44, Infosys Avenue, Hosur Road, Electronics City, Bengaluru, KA, India, 560 100 | https://www.infosys.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Accenture PLC Class A | View profile | 742000 | 1 Grand Canal Square, Grand Canal Harbour, Dublin, Ireland, 2 | https://www.accenture.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Oracle Corp | View profile | 164000 | 2300 Oracle Way, Austin, TX, United States, 78741 | https://www.oracle.com |
Middle East & Africa drug discovery informatics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery informatics market will help companies and investors design strategic landscapes.
Sequence analysis platforms was the largest segment with a revenue share of 40.23% in 2024. Horizon Databook has segmented the Middle East & Africa drug discovery informatics market based on sequence analysis platforms, molecular modelling, docking, clinical trial data management covering the revenue growth of each sub-segment from 2018 to 2030.
Conducting clinical trials in Middle East & Africa offers advantages such as patient diversity, cost advantage, infrastructure, and world-class medical facilities. Many regions are initiating to adapt to the global standards and collaborating with other global CROs to mark their presence.
Reasons to subscribe to Middle East & Africa drug discovery informatics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa drug discovery informatics market databook
-
Our clientele includes a mix of drug discovery informatics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa drug discovery informatics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa drug discovery informatics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA drug discovery informatics market size, by country, 2018-2030 (US$M)
Middle East & Africa Drug Discovery Informatics Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
